
Abcurorevenue
Newton, MassachusettsFounded 2015CEO Alex Martin
Abcuro is a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of immune responses.
Abcuro revenue
Abcuro has not published its revenue. Growjo puts it at about $10.2M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $10.2MEST | Growjo estimate |
Abcuro CEO & employees
Alex Martin is CEO of Abcuro. Abcuro has 55 employees (September 2025, LinkedIn).
- Alex MartinCEO
Abcuro FAQ
What is Abcuro's revenue?
Growjo estimates Abcuro's revenue at about $10.2M a year (September 2025). The company hasn't published its own figure.
How many employees does Abcuro have?
Abcuro has 55 employees as of September 2025, according to LinkedIn.
Who is the CEO of Abcuro?
Alex Martin is the CEO of Abcuro.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Abcuro? Join the podcast